Sangamo Biosciences (Nasdaq:SGMO) deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.
Recent Mentions on Fool.com
- Why Sangamo Biosciences, Inc. Trounced the Market
- Why Sangamo Biosciences Inc. Shares Surged
- Top Stories in Biotech This Morning: Pluristem Therapeutics, Inc, Rigel Pharmaceuticals, Inc. and Sa
- This Week in Biotech: Putting On a Clinic
- Why Intercept Pharmaceuticals, Sangamo Biosciences, and eHealth Are Today's 3 Best Stocks